Keltm1Slee
Targeted Allele Detail
|
Symbol: |
Keltm1Slee |
Name: |
Kell blood group; targeted mutation 1, Soohee Lee |
MGI ID: |
MGI:5581644 |
Gene: |
Kel Location: Chr6:41663263-41681268 bp, - strand Genetic Position: Chr6, 19.86 cM
|
Alliance: |
Keltm1Slee page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:212529
|
Parent Cell Line: |
RW-4 (ES Cell)
|
Strain of Origin: |
129X1/SvJ
|
|
Allele Type: |
|
Targeted (Null/knockout) |
Mutation: |
|
Intragenic deletion
|
|
|
Mutation details: A 3.2 kb segment spanning from the start of exon 11 into exon 16. This region includes the zinc binding enzymatically active site was reolaced with a neomycin resistance gene. Northern blot analysis confirmed the absence of mRNA and Western blot analysis demonstrated the absence of protein on RBC membranes.
(J:212529)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Kel Mutation: |
44 strains or lines available
|
|
Original: |
J:212529 Zhu X, et al., Changes in red cell ion transport, reduced intratumoral neovascularization, and some mild motor function abnormalities accompany targeted disruption of the Mouse Kell gene (Kel). Am J Hematol. 2009 Aug;84(8):492-8 |
All: |
3 reference(s) |
|